This study tests whether adding a new drug called SION-719 to the standard CF medication Trikafta is safe and helps people with cystic fibrosis who have two copies of the F508del mutation. Sixteen participants will receive either SION-719 or a placebo alongside their usual Trikaf…
Phase: PHASE2 • Sponsor: Sionna Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC